Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer (Q33772810)

29 July 2017

Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer (English)

1 reference

29 July 2017

1 reference

Gregory T Wolf

1

1 reference

29 July 2017

Willard E Fee

2

1 reference

29 July 2017

Robert W Dolan

3

1 reference

29 July 2017

Jeffrey S Moyer

4

1 reference

29 July 2017

Michael J Kaplan

5

1 reference

29 July 2017

Paul M Spring

6

1 reference

29 July 2017

James Suen

7

1 reference

29 July 2017

Daniel E Kenady

8

1 reference

29 July 2017

Jason G Newman

9

1 reference

29 July 2017

William R Carroll

10

1 reference

29 July 2017

M Boyd Gillespie

11

1 reference

29 July 2017

Scott M Freeman

12

1 reference

29 July 2017

Lorraine Baltzer

13

1 reference

29 July 2017

Terry D Kirkley

14

1 reference

29 July 2017

Harvey J Brandwein

15

1 reference

29 July 2017

John W Hadden

16

1 reference

29 July 2017

language of work or name

1 reference

31 January 2011

1 reference

29 July 2017

1 reference

29 July 2017

33

1 reference

29 July 2017

12

1 reference

29 July 2017

1666-1674

1 reference

A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Immunotherapy of head and neck cancer: current and future considerations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Head and neck cancer immunotherapy: clinical evaluation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

4 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Immunobiology of head and neck cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Global cancer statistics, 2002

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Reprogramming of the immune system during zinc deficiency

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062188

4 July 2018

1 reference

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

21 January 2018

1 reference

Crossref

Antidepressants, prostaglandins and the prevention and treatment of cancer.

21 January 2018

1 reference

Crossref

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

21 January 2018

1 reference

Crossref

Immunotherapy for head and neck cancer

21 January 2018

1 reference

12 December 2020

Prognostic significance of sinus histiocytosis in metastatic laryngeal cancer

1 reference

12 December 2020

Intravenous, intralesional and endolymphatic administration of lymphokines in human cancer

1 reference

12 December 2020

IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro

1 reference

12 December 2020

Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice

1 reference

12 December 2020

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma

1 reference

12 December 2020

Nutritional and zinc status of head and neck cancer patients: an interpretive review

1 reference

12 December 2020

Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose

1 reference

12 December 2020

Identifiers

DOI

10.1002/HED.21660

1 reference

29 July 2017

1 reference

29 July 2017

1 reference